Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

RNA Therapeutics 2017

Submit News
Date: 22-Feb-17 to 23-Feb-17
Location: Copthorne Tara Hotel / London / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

SMi’s 8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates and interactive workshops tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.

This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.

Join us next February to expand your scientific horizons on emerging concepts in nanoparticle delivery systems, small activating RNA and 3rd generation antisense technology. Plus, we’ll be honing in on under-met areas such as targeted delivery beyond the liver, and offering regulatory guidance on the reporting of clinical data through an exclusive MHRA keynote.

Speakers include:

• Nagy Habib, Head of Surgery, Co-Founder, Imperial College Healthcare NHS Trust, MiNA Therapeutics
• John Johnston, Clinical Assessor Biologicals & Biotechnology Unit, MHRA
• Heinrich Haas, Vice President RNA Formulation & Drug Delivery, BioNTech RNA
• Bo Rode Hansen, Global Head of RNA Therapeutics, Roche
• Nicole Meisner-Kober, Senior Investigator, RNA Biology, Novartis
• Steve Hood, Director, Bioimaging, GSK
• David Giljohann, CEO, Exicure
• Shai Erlich, Chief Medical Officer & President USA, Quark Pharmaceuticals
• Amotz Shemi, CEO, Silenseed
• Sanyogitta Puri, Associate Principal Scientist, AstraZeneca

Reasons to attend:

• Discover exciting developments of mRNA and antisense oligonucleotide based therapeutics
• Find out how pharmaceutical and biotech companies are strategically improving drug delivery systems
• Discuss clinical developments and take away key lessons for future developments
• Understand the pharmacokinetic considerations of oligonucleotides and RNA therapies
• Hear how the experts navigate the regulatory landscape

www.therapeutics-rna.com

Go to event website